Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Snizhana V. Feysa"'
Publikováno v:
Wiadomości Lekarskie. 74:2634-2639
The aim: Calculate CVR in patients with T2DM, obesity and SH and analyze it. Materials and methods: The selection of patients was carried out based on the Uzhhorod District Clinical Hospital, in the period from November 2016 to July 2021. All examine
Autor:
Snizhana V. Feysa, Svitlana O Rudakova
Publikováno v:
Wiadomości Lekarskie. 74:986-991
Objective The aim: Of this research is to evaluate laboratory changes in the liver blood tests, carbohydrate and lipid metabolism in NAFLD patients with concomitant pre-diabetes, and to study the feasibility of their complex treatment with the inclus
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 74(10 cz 2)
The aim: Calculate CVR in patients with T2DM, obesity and SH and analyze it.Materials and methods: The selection of patients was carried out based on the Uzhhorod District Clinical Hospital, in the period from November 2016 to July 2021. All examined
Autor:
Snizhana V. Feysa, Yaroslav O Mykhalko, Ivan V Chopey, Taras I. Griadil, Mykhaylo M Hechko, Kristian O. Debreceni
Publikováno v:
Wiadomości Lekarskie. 73:457-461
OBJECTIVE The aim: Evaluate clinical and laboratory parameters of the patients with type 2 diabetes mellitus and concomitant obesity after a course of dapagliflozin treatment and compare with a standard treatment regimen. PATIENTS AND METHODS Materia
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 74(4)
The aim: Of this research is to evaluate laboratory changes in the liver blood tests, carbohydrate and lipid metabolism in NAFLD patients with concomitant pre-diabetes, and to study the feasibility of their complex treatment with the inclusion of ome
Autor:
Ivan V Chopei, Snizhana V. Feysa
Publikováno v:
Wiadomości Lekarskie. 72:650-653
OBJECTIVE Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most common disease which is characterized by comorbidity. However, no comorbidity index for its assessment has been described yet. The aim of this study was to develop a new in
Autor:
Taras I, Griadil, Ivan V, Chopey, Kristian O, Debreceni, Mykhaylo M, Hechko, Yaroslav O, Mykhalko, Snizhana V, Feysa
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 73(3)
The aim: Evaluate clinical and laboratory parameters of the patients with type 2 diabetes mellitus and concomitant obesity after a course of dapagliflozin treatment and compare with a standard treatment regimen.Materials and methods: Conducted a comp
Autor:
Snizhana V, Feysa, Ivan V, Chopei
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 72(4)
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most common disease which is characterized by comorbidity. However, no comorbidity index for its assessment has been described yet. The aim of this study was to develop a new index for ev